Innovative Novel Ovarian cancer treatment Approaches
Line Bjørge LINE BJØRGE, MD, PhD, MBA holds the position as the Medical Director in Gynaecologic Oncology at the Department of Obstetrics and Gynaecology at Haukeland University Hospital, Bergen, Norway, and is responsible for treatment of gynaecological cancer for the Norwegian western region (a population of approximately 1 100 000). She is also a Read More ...
About INOvA In 70% of all cases, high grade serous ovarian cancer (HGSOC) is diagnosed at an advanced stage with spread into the peritoneal cavity. At present, successful debulking surgery followed by adjuvant chemotherapy, consisting of a combination of taxane and platinum based drugs, serves as the most efficient treatment options and enhances survival chances Read More ...
The INOvA team at the Onkologisk Forum 2019 meeting – Dr. Line Bjørge and Dr. Emmet McCormack The first session focused on immunotherapy and both the Nobel Laureate Jim Allison and the fabulous Padmanee Sharma from MD Anderson Cancer Center, University of Texas gave great talks. The session was hosted by Emmet Mc Cormack. The Read More ...
About INOvA In 70% of all cases, high grade serous ovarian cancer (HGSOC) is diagnosed at an advanced stage with spread into the peritoneal cavity. At present, successful debulking surgery followed by adjuvant chemotherapy, consisting of a combination of taxane and platinum based drugs, serves as the most efficient treatment options and enhances survival chances Read More ...
The INOvA team at the Onkologisk Forum 2019 meeting – Dr. Line Bjørge and Dr. Emmet McCormack The first session focused on immunotherapy and both the Nobel Laureate Jim Allison and the fabulous Padmanee Sharma from MD Anderson Cancer Center, University of Texas gave great talks. The session was hosted by Emmet Mc Cormack. The Read More ...
Line Bjørge LINE BJØRGE, MD, PhD, MBA holds the position as the Medical Director in Gynaecologic Oncology at the Department of Obstetrics and Gynaecology at Haukeland University Hospital, Bergen, Norway, and is responsible for treatment of gynaecological cancer for the Norwegian western region (a population of approximately 1 100 000). She is also a Read More ...
FORECEE project – First publication in Lancet Oncology – Line Bjørge We found that women with ovarian cancer had a significant reduction in vaginal lactobacilli. This significant reduction was also seen in women with BRCA1 gene mutation. The reduction in lactobacilli was more apparent the younger the women were, for both the women with ovarian Read More …
From our latest publication: “High levels of total Δ133p53 were found to be an independent prognosticator for improved overall survival of HGSOC. TP53 mutations resulting in loss of function or located at known hotspots were predictive of tumour characteristics and disease progression.” https://www.ncbi.nlm.nih.gov/m/pubmed/30918304/
Katharina Bischof – from the INOvA team defended her PhD thesis successfully on 08.02.2019, at the University of Bergen. Congratulations once again!!
Members at the meeting – Line Bjorge, Katrin Kleinmanns, Katharina Bischof, Liv Cecilie Vestriem Thomsen, Shamundeeswari Anandan, Vibeke Fosse, Cecilie Fredvik Torkildsen.
Congratulations! Cecilie Fredvik Torkildsen received a 3-years position from Helse Vest HF to complete her PhD project.
Tamim Abdelaal (ESR-3) (first in the pic) from TU Delft, a partner institute in the EU ISPIC Horizon 2020 project, is in Bergen to do some quality research with the other ISPIC ESR’s in Bergen – Vibeke Fosse (ESR-20), Katrin Kleinmanns (ESR-9), Shamundeeswari Anandan (ESR-1) (as in the picture from right to left).
New Campaign Launched by the German Ovarian Cancer Foundation for the World Ovarian Cancer Day. For more details please follow the link below – https://mailchi.mp/esgomail/world-ovarian-cancer-day?e=4b579edbaa
There is a new job opening at the SonoCURE Team, focusing on “Development of Pre-clinical models in Pancreatic Cancer”. For more details, please contact Prof. Dr. Emmet Mc Cormack – emmet.mc.cormack @ med.uib.no and to apply follow the link https://www.jobbnorge.no/en/available-jobs/job/150966/researcher
Dr. Line Bjørge is the New President of NSGO https://nsgo.org/
https://www.nature.com/articles/nrclinonc.2018.30 – Dr. Line Bjørge at Haukeland universitetssjukehus.